Cargando…

NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction

Detalles Bibliográficos
Autores principales:	Mai, Thach, Markov, Glenn, Brady, Jennifer J., Palla, Adelaida, Zeng, Hong, Sebastiano, Vittorio, Blau, Helen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101038/ https://www.ncbi.nlm.nih.gov/pubmed/30013107 http://dx.doi.org/10.1038/s41556-018-0136-x

Ejemplares similares

Transient Acquisition of Pluripotency During Somatic Cell Transdifferentiation with iPSC Reprogramming Factors
por: Maza, Itay, et al.
Publicado: (2015)

Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014)

Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency
por: Gu, Qi, et al.
Publicado: (2016)

Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming
por: Milagre, Inês, et al.
Publicado: (2017)

Suspension culture improves iPSC expansion and pluripotency phenotype
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023)

Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)

OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
por: Kagawa, Harunobu, et al.
Publicado: (2019)

iPSC reprogramming-mediated aneuploidy correction in autosomal trisomy syndromes
por: Akutsu, Silvia Natsuko, et al.
Publicado: (2022)

Attenuating iPSC reprogramming stress with dominant-negative BET peptides
por: Hossain, Md Emon, et al.
Publicado: (2022)

Mouse iPSC generated with porcine reprogramming factors as a model for studying the effects of non-silenced heterologous transgenes on pluripotency
por: Petkov, Stoyan G, et al.
Publicado: (2017)

Improvement in Mouse iPSC Induction by Rab32 Reveals the Importance of Lipid Metabolism during Reprogramming
por: Pei, Yangli, et al.
Publicado: (2015)

Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level
por: Sui, Dandan, et al.
Publicado: (2014)

Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming
por: Janiszewski, Adrian, et al.
Publicado: (2019)

Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
por: Tidball, Andrew M., et al.
Publicado: (2017)

Chromatin looping is needed for iPSC induction
por: Hu, Ji-Fan, et al.
Publicado: (2014)

Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy
por: Wong, Raymond C.B., et al.
Publicado: (2017)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
por: Tang, Yu, et al.
Publicado: (2017)

Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming
por: Fu, Kai, et al.
Publicado: (2018)

Stable iPSC-derived NKX2-1(+) lung bud tip progenitor organoids give rise to airway and alveolar cell types
por: Hein, Renee F. C., et al.
Publicado: (2022)

MiR-106b-5p Regulates the Reprogramming of Spermatogonial Stem Cells into iPSC (Induced Pluripotent Stem Cell)-Like Cells
por: Hasani Fard, Amir Hossein, et al.
Publicado: (2022)

A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

Automating iPSC generation to enable autologous photoreceptor cell replacement therapy
por: Bohrer, Laura R., et al.
Publicado: (2023)

Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species
por: Ogorevc, J., et al.
Publicado: (2016)

Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming
por: Tan, Li, et al.
Publicado: (2017)

Understanding the Molecular Basis of iPSC Reprogrammed Cells to Fulfil Their Expectations in Future Clinical Applications
por: González-Fernández, Verónica, et al.
Publicado: (2022)

Counteracting Activities of OCT4 and KLF4 during Reprogramming to Pluripotency
por: Tiemann, Ulf, et al.
Publicado: (2014)

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors
por: Walczak, Maciej P., et al.
Publicado: (2016)

NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency
por: Matlock, Andrea D., et al.
Publicado: (2023)

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC
por: Kim, Bu-Yeo, et al.
Publicado: (2016)

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming
por: Generoso, Serena F., et al.
Publicado: (2023)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

iPSC diversity: A key for better use and improved targeting
por: Abbonante, Vittorio, et al.
Publicado: (2021)

Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
por: Kawamata, Shin, et al.
Publicado: (2015)

Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis
por: Kammers, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nm721k9vder7uaj1fp52eoo8dt